STOCK TITAN

LifeStance (LFST) CPO logs RSU, PSU vesting and tax share withholding

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LifeStance Health Group Chief People Officer Ann Varanakis reported compensation-related share activity in connection with vested restricted stock units (RSUs) and performance-based RSUs (PSUs) on March 9, 2026.

She acquired 26,836 and 59,789 shares of common stock at $0.00 per share through RSU and PSU settlements. To cover tax withholding obligations on these vestings, the issuer withheld a total of 44,963 shares at a reference price of $6.91 per share. The footnotes state these withholdings reduce shares delivered and do not involve any open-market sales. Following these transactions, Varanakis directly holds 422,037 shares of LifeStance common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Varanakis Ann

(Last) (First) (Middle)
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)
SCOTTSDALE AZ 85251

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/09/2026 F(1) 8,707 D $6.91 371,668 D
Common Stock 03/09/2026 A 26,836(2) A $0.00 398,504 D
Common Stock 03/09/2026 F(3) 11,232 D $6.91 387,272 D
Common Stock 03/09/2026 A 59,789(4) A $0.00 447,061 D
Common Stock 03/09/2026 F(5) 25,024 D $6.91 422,037 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
2. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
3. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
4. Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
5. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
By: /s/ Ryan Pardo, Attorney-in-Fact 03/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did LFST Chief People Officer Ann Varanakis report?

Ann Varanakis reported RSU and PSU vesting-related share movements. She received two grants of common stock through settlement of RSUs and PSUs, and shares were withheld by the company to cover tax obligations, with no open-market sales involved according to the footnotes.

How many LifeStance (LFST) shares were withheld for Ann Varanakis’s taxes?

The company withheld 44,963 LFST shares for tax obligations. These shares, referenced at $6.91 per share, satisfied withholding taxes on vested RSUs and PSUs and reduced the net shares delivered, without any open-market sale activity.

How many LifeStance (LFST) shares did Ann Varanakis receive from RSU and PSU vesting?

She acquired 26,836 and 59,789 LFST shares from awards. These common shares were credited at $0.00 per share as part of RSU and PSU settlements, reflecting equity compensation rather than open-market stock purchases.

Did Ann Varanakis sell LifeStance (LFST) shares in the open market?

No open-market sales were reported for these transactions. Footnotes explain that all disposals were shares withheld by the issuer to satisfy tax withholding obligations on vested RSUs and PSUs, not discretionary market sales.

What is Ann Varanakis’s LifeStance (LFST) shareholding after these transactions?

After the reported transactions, she directly holds 422,037 shares. This post-transaction balance reflects RSU and PSU settlements net of shares withheld by the company to cover associated tax liabilities on March 9, 2026.

What do the F-coded transactions mean in the LFST Form 4 for Ann Varanakis?

The F-coded entries represent tax-withholding dispositions. They show shares delivered back to LifeStance at $6.91 per share value to cover RSU and PSU tax obligations, rather than voluntary sales of stock into the market.
Lifestance Health Group, Inc.

NASDAQ:LFST

View LFST Stock Overview

LFST Rankings

LFST Latest News

LFST Latest SEC Filings

LFST Stock Data

2.54B
165.19M
Medical Care Facilities
Services-health Services
Link
United States
SCOTTSDALE